Author(s): Shubham Kanawade, Deokar Shreyash, Bhosale Krutika, Naik Mayur, Harish Pawar

Email(s): shubhamkanawade96pims@gmail.com

DOI: 10.52711/0975-4377.2024.00025   

Address: Shubham Kanawade*, Deokar Shreyash, Bhosale Krutika, Naik Mayur, Harish Pawar
Department of Pharmaceutics, College of Pharmaceutical Sciences, Pravara Institute of Medical Sciences (DU), Loni, Ahmednagar, Maharashtra, India.
*Corresponding Author

Published In:   Volume - 16,      Issue - 2,     Year - 2024


ABSTRACT:
Cancer continues to be a major cause of sickness and death in the world's health. Conventional cancer treatments, such radiation and chemotherapy, frequently have drawbacks like poor solubility, limited absorption, and non-specific targeting, which can result in systemic toxicity and decreased efficacy. To get over these restrictions and improve cancer therapy, nanosuspensions—submicron colloidal dispersions of drug particles stabilized by polymers and/or surfactants—have become a viable new approach. This review provides a comprehensive overview of nanosuspensions, including their preparation methods, characterization techniques, and therapeutic applications in cancer treatment. The potential advantages of nanosuspensions over conventional formulations, such as improved solubility, enhanced bioavailability, and tumor-targeted delivery, are discussed in detail. The potential advantages of nanosuspensions over conventional formulations, such as improved solubility, enhanced bioavailability, and tumor-targeted delivery, are discussed in detail. Recent advances in nanosuspension technology, including the development of stimuli-responsive and multifunctional nanosuspensions, are also highlighted. Recent advances in nanosuspension technology, including the development of stimuli-responsive and multifunctional nanosuspensions, are also highlighted. Finally, the challenges and future directions of nanosuspensions in cancer therapy are explored.


Cite this article:
Shubham Kanawade, Deokar Shreyash, Bhosale Krutika, Naik Mayur, Harish Pawar. Research Journal of Pharmaceutical Dosage Forms and Technology.2024; 16(2):157-2. doi: 10.52711/0975-4377.2024.00025

Cite(Electronic):
Shubham Kanawade, Deokar Shreyash, Bhosale Krutika, Naik Mayur, Harish Pawar. Research Journal of Pharmaceutical Dosage Forms and Technology.2024; 16(2):157-2. doi: 10.52711/0975-4377.2024.00025   Available on: https://rjpdft.com/AbstractView.aspx?PID=2024-16-2-6


REFERENCES:
1.    Maeda HA, Matsumura Y. Tumoritropic and lymphotropic principles of macromolecular drugs. Critical Reviews in Therapeutic Drug Carrier Systems. 1989 Jan 1; 6(3):193-210.
2.    Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. Journal of Pharmacy and Pharmacology. 2004 Jul; 56(7):827-40.
3.    Ali HS, York P, Blagden N. Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. International Journal of Pharmaceutics. 2009 Jun 22; 375(1-2):107-13.
4.    Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacological Reviews. 2001 Jun 1; 53(2):283-318.
5.    De Verdiere AC, Dubernet C, Nemati F, Poupon MF, Puisieux F, Couvreur P. Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells. Cancer Chemotherapy and Pharmacology. 1994 Nov; 33:504-8.
6.    Leamon CP. Folate-targeted drug strategies for the treatment of cancer. Current Opinion in Investigational Drugs (London, England: 2000). 2008 Dec 1; 9(12): 1277-86.
7.    Yao H, Ng SS, Tucker WO, Man K, Wang XM, Chow BK, Kung HF, Tang GP, Lin MC. The gene transfection efficiency of a folate–PEI600–cyclodextrinnanopolymer. Biomaterials. 2009 Oct 1; 30(29):5793-803.
8.    Kim YK, Choi JY, Yoo MK, Jiang HL, Arote R, Je YH, Cho MH, Cho CS. Receptor-mediated gene delivery by folate-PEG-baculovirus in vitro. Journal of Biotechnology. 2007 Sep 15; 131(3):353-61.
9.    Keck C, Muller R. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization. European Journal of Pharmaceutics and Biopharmaceutics. 2006; 62(1):3–16.
10.    Nash R.A. Suspensions. In: Swarbrick J, Boylan J.C (Ed). Encyclopedia of Pharmaceutical Technology. Second edition vol. 3. New York, Marcel Dekker, 2002, p. 2045-3032.
11.    RH Muller, C Jacobs and O Kayer. Nanosuspensions for the formulation of poorly soluble drugs. In: F Nielloud, G Marti- Mestres (Ed). Pharmaceutical Emulsion and Suspension. New York, Marcel Dekker, 2000, p. 383-407.
12.    Cornelia M. Keck, Rainer H. Muller. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization. European Journal of Pharmaceutics and Biopharmaceutics.2006; 62: 3–16
13.    Dearns R. Atovaquone Pharmaceutical Compositions. US Patent US 6018080, 2000.
14.    Prassanna, A. K. Giddam, Nanosuspensions technology, a review. International Journal of Pharmaceutics. 2010:2(4): 35-40.
15.    GG Liversidge, KC Cundy, JF Bishop and DA Czekai. Surface Modified Drug Nanoparticles.US Patent 5, 145, 684, 199.
16.    VB Patravale, AA Date and RM Kulkarni. Nanosuspension: a promising drug delivery strategy. Journal of Pharmacology and Pharmacotherapeutics. 2004; 56, 827 40.2003; 254:235–42
17.    Trotta M, Gallarate M, Carlotti ME, Morel S. Preparation of griseofulvin nanoparticles from water-dilutable microemulsions. International Journal of Pharmaceutics. 2003; 254:235–42
18.    Trotta M, Gallarate M, Carlotti ME, Morel S. Preparation of griseofulvin nanoparticles from water-dilutable microemulsions. International Journal of Pharmaceutics.
19.    Young TJ, Mawson S, Johnston KP, Henriska IB, Pace GW, Mishra AK. Rapid expansion from supercritical to aqueous solution to produce submicron suspension of water insoluble drugs. Biotechnology Progress. 2000; 16:402–7.
20.    N Arunkumar, M Deecaraman and C Rani, Nanosuspension technology and its applications in drug delivery, Asian Journal of Pharmaceutics, 2009, 168-173.
21.    Muller RH, Keck CM. Challenges and solutions for the delivery of biotech drugs–a review of drug nanocrystal technology and lipid nanoparticles. Journal of Biotechnology. 2004 Sep 30; 113(1-3):151-70.
22.    Kesisoglou F, Panmai S, Wu Y. Nanosizing—oral formulation development and biopharmaceutical evaluation. Advanced Drug Delivery Reviews. 2007 Jul 30; 59(7):631-44.
23.    Kesisoglou F, Panmai S, Wu Y. Nanosizing—oral formulation development and biopharmaceutical evaluation. Advanced Drug Delivery Reviews. 2007 Jul 30; 59(7):631-44.
24.    Bhadra D, Bhadra S, Jain S, Jain NK. A PEGylated dendritic nanoparticulate carrier of fluorouracil. International Journal of Pharmaceutics. 2003 May 12; 257(1-2):111-24.
25.    Aher SS, Malsane ST, Saudagar RB. Nanosuspension: an overview. Asian Journal of Research in Pharmaceutical Science. 2017; 7(2):81-6.
26.    Kulkarni RR, Phadtare DG, Saudagar RB. A novel approach towards nanosuspension. Asian Journal of Pharmaceutical Research. 2015; 5(4):186-94.
27.    Dode HR, Prasad SM, Pagar NU, Pansare JJ, Surawase KR. Nanosuspension a promising tool for solubility enhancement: A review. Asian Journal of Pharmacy and Technology. 2021; 11(3): 252-8.
28.    Khandbahale SV. A review-Nanosuspension technology in drug delivery system. Asian Journal of Pharmaceutical Research. 2019; 9(2): 130-8.
29.    Pravin P, Adhikrao Y, Varsha G. Different Techniques for Preparation of Nanosuspension with Reference to its Characterisation and various Applications-A Review. Asian Journal of Research in Pharmaceutical Science. 2018; 8(4): 210-6.
30.    Phatak A, Jorwekar P, Chaudhari PD. Nanosuspensions: A Promising Nanocarrier Drug Delivery System. Research Journal of Pharmaceutical Dosage Forms and Technology. 2011; 3(5): 176-82.

Recomonded Articles:

Author(s): Gopal Rao M., M. A. Amutha Gnana Arasi, S. Jayaprakash, M. Arun Kumar, P. Kavitha

DOI:         Access: Open Access Read More

Author(s): V. S. Parmar, S.C. Shivhare

DOI:         Access: Open Access Read More

Author(s): Domendra Sahu, Shekhar Verma , Ravindra D. Dubey

DOI:         Access: Open Access Read More

Author(s): Hapse S.A., Bhagat B.V., Wagh V.S. , Kadaskar P.T.

DOI:         Access: Open Access Read More

Author(s): Pratik Swarup Das, Puja Saha1, Krishan, Rumpa Das

DOI: :10.5958/0975-4377.2018.00005.8         Access: Open Access Read More

Author(s): Swapnil T. Deshpande, P. S. Vishwe, Rohit D. Shah, Swati S. Korabu, Bhakti R. Chorghe, DG Baheti

DOI:         Access: Open Access Read More

Author(s): Suyash Ingle, Varsha Tegeli, Akshay Javalgikar, Vinod Matole, Lagmanna koli, Avinash Birajdar, Saurabh Nangare, Sagar Adlinge, Swaminath Ramanshetti, Akhil Patil, Yash Kothari, Pandurang Choure, Aaqueeb Mangalgiri, Sneha Ubale, Vaishnavi Dulange, Bhavana habib, Jyoti Mittha

DOI: 10.5958/0975-4377.2021.00013.6         Access: Open Access Read More

Author(s): Dipti G. Phadtare, Amol R. Pawar, R.B. Saudagar, Govind K.Patil

DOI: 10.5958/0975-4377.2017.00002.7         Access: Open Access Read More

Author(s): Yamunappa, Ravi Kumar, Pooja Shetty, Prathibha Suvarna, Narayana Swamy VB

DOI: 10.5958/0975-4377.2016.00012.4         Access: Open Access Read More

Author(s): Simila Madathil, RaviKumar, Anju Govind, Mercy Mathew, Narayana Swamy VB

DOI: 10.5958/0975-4377.2016.00013.6         Access: Open Access Read More

Author(s): Shraddha Jethawa, Onkar Gopale, Suvarna Shelke

DOI: 10.52711/0975-4377.2022.00035         Access: Closed Access Read More

Author(s): Amallia Rachmasari, Rafidha Aisyah Kartini, Gita Alviani, Indah Solihah

DOI: 10.5958/0975-4377.2019.00046.6         Access: Open Access Read More

Author(s): Soham Shukla, Vikram Pandya, Praful Bhardia, Nitin Jonwal, Shashank Mishra, Deepak Bhatt, Deependra Jain

DOI:         Access: Open Access Read More

Author(s): Dharmendra Kumar Kushwah, Prakash Yashwant Kohle, Bimal Kumar Srivastava, Manoj Parmar ,Dhaval Mehta

DOI:         Access: Open Access Read More

Author(s): Chirag A. Patel, Priyal R. Patel, Dhrubo Jyoti Sen,Jayvadan K. Patel

DOI:         Access: Open Access Read More

Author(s): Vidya N. Dange, Shubhangi J. Shid, Sagar B. Patil, Ganesh B. Vambhurkar, Mangesh A. Bhutkar

DOI: 10.5958/0975-4377.2019.00010.7         Access: Open Access Read More

Research Journal of Pharmaceutical Dosage Forms and Technology (RJPDFT) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. ...... Read more >>>

RNI: Not Available                     
DOI: 10.5958/0975-4377 


Recent Articles




Tags